Atlas Trials

Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

Clinical trial NCT05764720 · RECRUITING

Trial details

NCT number
NCT05764720
Sponsor
Varian, a Siemens Healthineers Company
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2023-05-14
Primary completion
2028-03-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.